Masimo narrows Q4 revenue view to $601M from $581M-$611M, consensus $591.7M

The company said, “Healthcare revenue is expected to be approximately $368 million, representing 8% growth on a reported basis and 9% growth on a constant currency basis; Non-healthcare revenue is expected to be approximately $232 million, representing 11% growth on a reported and constant currency basis; and Shipments of noninvasive technology boards and instruments are expected to be approximately 65 thousand.”